Paper Details

  1. Home
  2. Paper Details

[Myocardial infarction in a patient free of coronary artery disease].

Author: AnttonenOlli, EkströmKaj, LönnbergAnnika

English AbstractA summary of a research paper/publication written in English for a wider audience.
Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Triptans are used to treat migraine attacks, but they can also cause vasoconstriction in the coronary arteries. While mild chest symptoms are common, severe cardiovascular events are rare. However, a case of zolmitriptan-induced myocardial infarction was reported in a patient without coronary artery disease, highlighting the potential risk.
Paper Details　
Original Abstract of the Article :
Triptans are widely used for treating migraine attacks. Their mechanism of action is attributable to cerebrovascular vasoconstriction. Vasoconstriction can occur also in the coronary arteries. Mild chest symptoms not related to myocardial ischemia have been reported among triptan users. Severe cardi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/27400593

データ提供：米国国立医学図書館（NLM）

Zolmitriptan and Myocardial Infarction: A Cautionary Tale From the Desert of Migraine Treatment

We're venturing into the often-unpredictable desert of migraine treatment, where unexpected side effects can arise. This case report, like a lone traveler encountering a treacherous sandstorm, explores the potential cardiovascular risk associated with zolmitriptan, a commonly prescribed medication for migraine headaches.

Zolmitriptan: A Hidden Danger in the Desert of Migraine Treatment?

The case report describes a patient who experienced a myocardial infarction (heart attack) after taking zolmitriptan, despite having no prior history of coronary artery disease. Imagine a traveler, seemingly safe in the desert, suddenly encountering a hidden pitfall. Zolmitriptan, in this analogy, represents the pitfall, highlighting the potential for unexpected cardiovascular complications, even in individuals without known heart disease.

Navigating the Desert of Migraine Treatment with Awareness

This case report, like a cautionary tale shared around a campfire, serves as a reminder of the potential risks associated with migraine medications. It emphasizes the importance of careful consideration of individual patient factors, such as cardiovascular history, and the need for open communication between patients and their healthcare providers.

Dr.Camel's Conclusion

Navigating the desert of migraine treatment requires vigilance. While zolmitriptan can be effective for many patients, this case report underscores the need to be aware of potential risks. Just as a traveler must be wary of unseen dangers in the desert, we must approach migraine medications with caution, considering both potential benefits and risks.

Date :
  1. Date Completed 2016-08-02
  2. Date Revised 2016-07-12
Further Info :

Pubmed ID

27400593

DOI: Digital Object Identifier

27400593

Related Literature

Article Analysis
・Effects of zolmitriptan
SNS
PICO Info
in preparation
Languages

Finnish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.